Cancer Medicine (Sep 2023)

High‐intensity interval training in breast cancer patients: A systematic review and meta‐analysis

  • Xudong Chen,
  • Xuyuan Shi,
  • Zhiruo Yu,
  • Xuelei Ma

DOI
https://doi.org/10.1002/cam4.6387
Journal volume & issue
Vol. 12, no. 17
pp. 17692 – 17705

Abstract

Read online

Abstract Background Women with breast cancer and improved survival often experience treatment‐related impairments. High‐intensity interval training (HIIT) has emerged as a promising exercise therapy modality for adult cancer patients. However, the overall effects of HIIT in breast cancer patients remain scarce and controversial. Therefore, we conducted a systematic review and meta‐analysis to comprehensively evaluate the impact of HIIT on health‐related outcomes in breast cancer patients. Methods We searched the PubMed, Embase, and Web of Science from inception to November 7, 2022. Eligible studies included randomized controlled trials that compared HIIT interventions with usual care (UC) or MICT in breast cancer patients. The primary outcome assessed was physical fitness, and exploratory outcomes included body composition, blood‐borne biomarkers, and patient‐reported outcomes. Summary data were extracted, and standardized mean differences (SMD) were calculated for meta‐analysis. For outcomes that could not be pooled, a systematic review was conducted. Results Our analysis included 19 articles from 10 studies, encompassing 532 participants who met the inclusion criteria. Pooled results demonstrated that HIIT was superior to UC in improving peak oxygen uptake (VO2peak). The SMD for VO2peak (L/min) and VO2peak (mL/kg/min) was 0.79 (95% CI 0.13, 1.45) and 0.59 (95% CI 0.01, 1.16), respectively. No significant differences in VO2peak were found between the HIIT and MICT groups. Meta‐analyses on body composition and blood‐borne biomarkers showed no significant differences between HIIT and UC. Systematic review indicated favorable effects of HIIT on muscle strength, fatigue, and emotional well‐being. Conclusions HIIT is a time‐efficient alternative to MICT for improving VO2peak and may also enhance muscle strength and alleviate fatigue and emotional symptoms in breast cancer patients. HIIT should be considered as an important component of exercise prescription in breast cancer care. Further studies with larger cohorts are needed to determine the clinical significance of HIIT‐induced changes in terms of other outcomes in women with breast cancer.

Keywords